Orphinic Scientific is a biopharma portfolio platform. The company focuses on solutions for orphan diseases and other indications with significant unmet medical needs in the clinical trial phase. With 8 projects in the pipeline, Orphinic Scientific operates in three healthcare segments: therapeutics, medtech, and e-health. The company is also developing a therapy for pain management, focusing on a new drug formulation containing tramadol and magnesium booster for Osteoarthritis. Led by a C-level executive with 20+ years of international experience in the pharma and healthcare sector, Orphinic Scientific targets a total market for heart failure treatments worth >40 bln USD.
Headquarters
Ul. Postepu 21B
Warsaw; Mazowieckie;
Postal Code: 02-676
Contact Details: Purchase the Orphinic Scientific S.A. report to view the information.
Website: http://www.orphinic.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service